Official UK procurement notice
Capital Purchase of Genetic Screening Processor and Panthera Punch
Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)
What is being bought
Published requirement descriptionThe Cardiff and Vale University Health Board have a requirement to replace the current Newborn Screening Analysers used for CHT and CF screening. The current equipment is at the end of life, as well as nearing discontinuation. Replacement is required with the newer version, the Revvity Genetic Service Processor (GSP) to ensure continuity of service provision, In addition to replacing the GSP, there is also a need to replace the current Panther multi puncher that is also at the very end of its lifespan
CPV: Analysers · Medical equipments
The lotProcurement structure
single lot · no lot value publishedLot #1Funding was approved to replace equipment within the Newborn Screening department that…Awarded
Funding was approved to replace equipment within the Newborn Screening department that is nearing the end of lifespan. The replacement kit will allow continuity of service with no clinical risk impact.
The equipment will be provided with a 12 month warranty. Additional information: The contract has been awarded on a direct award basis against the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Framework Ref 2023/S 000-028831 under PCR2015 regulations.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 3 Jun 2026, 16:47 BST
- Last source update
- 3 Jun 2026, 16:47 BST
- Authority reference
CAV-DCO (25-26) 305- FTS notice number
2026/S 000-052501- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06accfFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The contract has been awarded on a direct award basis against the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Framework Ref 2023/S 000-028831. The framework was originally awarded under PCR2015 regulations.
Publisher note: (WA Ref:165966)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Revvity (UK) Ltd. | £511,496 † | — | Awarded |
Contracts
Contract 052501-2026-CAV-DCO (25-26) 305-1 · Revvity (UK) Ltd.
- Signed
- 16 Mar 2026
- Value
- £511,496
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- REVVITY (UK) LIMITEDAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.